• Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic VariantsResults From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
    • Silvestri V, Leslie G, Barnes DR, the CIMBA Group.
    • JAMA Oncol. 2020 Jul 2. doi: 10.1001/jamaoncol.2020.2134. [Epub ahead of print]